Suppr超能文献

偏头痛预防的最新进展。

Update on the prophylaxis of migraine.

机构信息

Hans-Christoph Diener, MD Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany

出版信息

Curr Treat Options Neurol. 2008 Jan;10(1):20-9. doi: 10.1007/s11940-008-0003-3.

Abstract

Migraine prophylaxis is a stepwise procedure with lifestyle advice followed by consideration of medications. Patients should be advised to try to maintain a regular lifestyle, with regular sleep, meals, exercise, and management of stress, perhaps through relaxation techniques or other ways that are sensible for them. If this regimen does not adequately control their migraines, preventatives are indicated. Patients can choose between evidence-based nutraceuticals such as riboflavin, feverfew, butterbur, or coenzyme Q10, or more traditional pharmacotherapeutics. Medicine choices are somewhat limited by what is available in each country, but from the full range, the medicines of first choice are beta-adrenoceptor blockers, flunarizine, topiramate, and valproic acid. Beta-adrenoceptor blockers are particularly useful in patients also suffering from hypertension or tachycardia. Following recent studies, topiramate has become a first choice for episodic as well as chronic migraine. It is the only prophylactic drug that may lead to weight loss, but it is sometimes associated with adverse cognitive effects. Valproic acid and flunarizine also have very good prophylactic properties. However, valproic acid is often associated with adverse effects, and flunarizine is unavailable in many countries, including the United States. If sequential monotherapies are ineffective, combinations of first-line drugs should be tried before advancing to drugs of second choice, which are associated with more adverse effects or have less well-established prophylactic properties. Amitriptyline should be used carefully because of its anticholinergic effects, although it is useful in comorbid tension-type headache, depression, and sleep disorders. Methysergide is very effective, but it has been supplanted or even made unavailable in many countries because of its well-described association with retroperitoneal fibrosis. Pizotifen has a slightly better safety profile but is unavailable in the United States. Aspirin is particularly useful in patients needing platelet inhibitors for other medical conditions, but the risk of gastrointestinal bleeding must be considered. The prophylactic properties of magnesium, riboflavin, and coenzyme Q10 are low at best, but their lack of severe adverse effects makes them good treatment options. Magnesium may be particularly useful during pregnancy. Lisinopril and candesartan were shown to be effective in single trials and are preferable in patients with hypertension. Acupuncture may be another alternative; although controlled trials have failed to differentiate its effect from placebo, it is at least innocuous. Botulinum toxin A is not effective in the prophylaxis of episodic migraine.

摘要

偏头痛预防是一个逐步进行的过程,首先是生活方式建议,然后再考虑药物治疗。建议患者尽量保持规律的生活方式,包括规律的睡眠、饮食、锻炼和应对压力,也许可以通过放松技巧或其他对他们来说合理的方式。如果这种生活方式不能充分控制他们的偏头痛,就需要使用预防性药物。患者可以在基于证据的营养保健品(如核黄素、小白菊、贯叶连翘或辅酶 Q10)和更传统的药物治疗之间进行选择。药物选择在一定程度上受到每个国家供应情况的限制,但在所有药物中,首选药物是β-肾上腺素受体阻滞剂、氟桂利嗪、托吡酯和丙戊酸。β-肾上腺素受体阻滞剂在同时患有高血压或心动过速的患者中特别有用。最近的研究表明,托吡酯已成为发作性和慢性偏头痛的首选药物。它是唯一可能导致体重减轻的预防性药物,但它有时会引起认知不良反应。丙戊酸和氟桂利嗪也具有很好的预防作用。然而,丙戊酸常伴有不良反应,而且氟桂利嗪在许多国家(包括美国)都无法获得。如果单药序贯治疗无效,应尝试联合使用一线药物,然后再使用二线药物,因为二线药物的不良反应更多或预防性作用尚未得到充分证实。阿米替林由于其抗胆碱能作用,应谨慎使用,尽管它对并发紧张型头痛、抑郁和睡眠障碍有效。美西麦角非常有效,但由于其与腹膜后纤维化的明确关联,在许多国家已被替代甚至无法获得。哌唑嗪的安全性稍好,但在美国无法获得。阿司匹林在需要血小板抑制剂治疗其他疾病的患者中特别有用,但必须考虑胃肠道出血的风险。镁、核黄素和辅酶 Q10 的预防作用充其量也很低,但它们没有严重的不良反应,使其成为良好的治疗选择。镁在怀孕期间可能特别有用。依那普利和坎地沙坦在单项试验中显示有效,在高血压患者中更可取。针灸可能是另一种选择;尽管对照试验未能区分其与安慰剂的效果,但它至少是无害的。肉毒杆菌毒素 A 对发作性偏头痛的预防无效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验